Impact of deforestation and subsequent land-use diversity on active carbon (AC), fulvic acid (FA), humic acid (HA), and glucose equivalent total non-humic carbon (NH) lability indi... by Emmanuel Amoakwah (13228938)

Subjects:

Impact of deforestation and subsequent land-use diversity on total organic carbon (SOC), total nitrogen (TN), active carbon (AC), fulvic acid (FA), humic acid (HA), humin, and gluc... by Emmanuel Amoakwah (13228938)

Subjects:

Impact of deforestation and subsequent land-use diversity on total organic carbon (SOC), total nitrogen (TN), active carbon (AC), fulvic acid (FA), humic acid (HA), humin, and gluc... by Emmanuel Amoakwah (13228938)

Subjects:

Impact of deforestation and subsequent land-use diversity on the stratification of total organic carbon (SOC), total nitrogen (TN), active carbon (AC), fulvic acid (FA), humic acid... by Emmanuel Amoakwah (13228938)

Subjects:

Predictive Significance of Glycosyltransferase-Related lncRNAs in Endometrial Cancer: A Comprehensive Analysis and Experimental Validation by Xiaoyu Shen (4715430)

“…And the low-risk cohort exhibited increased immune infiltration and decreased tumor purity. Additionally, significant differences in tumor mutation profiles were observed, with the tumor mutation burden (TMB) being higher in the low-risk cohort, suggesting a potentially better response to immunotherapy. …”

Synthesis, Preclinical Evaluation, and First-in-Human PET Study of Quinoline-Containing PSMA Tracers with Decreased Renal Excretion by Xiaojun Zhang (178074)

Frequencies of peripheral blood immune cells with each profile in SVR patients before and after OBV/PTV/r therapy by paired comparison analysis for each patient. by Miyabi Miura (18605126)

Subjects:

Consolidated standard of reporting trials (CONSORT) diagram. by Miyabi Miura (18605126)

Subjects:

TBX21 determination from candidate genes by PD-1+Treg- or PD-1+CD8+-related immune profile. by Miyabi Miura (18605126)

Subjects:

Raw data of frequencies of peripheral blood immune cells with each profile for DCV/ASV treatment. by Miyabi Miura (18605126)

Subjects:

Frequencies of peripheral blood immune cells with each profile in the non-SVR group before and after OBV/PTV/r therapy. by Miyabi Miura (18605126)

Subjects:

Frequencies of peripheral blood immune cells with each profile in all patients before and after OBV/PTV/r therapy by paired comparison analysis for each patient. by Miyabi Miura (18605126)

Subjects:

Frequencies of peripheral blood immune cells with each profile in patients before and after DCV/ASV therapy. by Miyabi Miura (18605126)

Subjects:

Consolidated standard of reporting trials (CONSORT) diagram. by Miyabi Miura (18605126)

Subjects:

Frequencies of peripheral blood immune cells with each profile in SVR and non-SVR cases for DCV/ASV treatment. by Miyabi Miura (18605126)

Subjects:

Patient characteristics for OBV/PTV/r treatment. by Miyabi Miura (18605126)

Subjects:

Frequencies of peripheral blood immune cells with each profile in SVR and non-SVR cases. by Miyabi Miura (18605126)

Subjects:

Frequencies of peripheral blood immune cells with each profile in the SVR cases before and after OBV/PTV/r treatment. by Miyabi Miura (18605126)

Subjects:

Graphical representation of before OBV/PTV/r treatment by Gene Ontology (GO) enrichment of differentially expressed genes between the SVR and non-SVR groups and analysis of the can... by Miyabi Miura (18605126)

Subjects:

Raw data of frequencies of peripheral blood immune cells with each profile for OBV/PTV/r treatment. by Miyabi Miura (18605126)

Subjects: